Genomic profiling salivary duct carcinomas (SDCs) reveals that RET is frequently altered in this tumor type, with three clinical cases presenting with RET fusion products, CCDC6-RET or NCOA4-RET (55). This evidence concerns the gene RET and neoplasm.